Table 3.
Low-risk (n = 101) | High-risk (n = 96) | |
---|---|---|
Beta-blocker (n, %) | 54 (53%) | 86 (90%) |
Aspirin (n, %) | 66 (65%) | 69 (72%) |
Warfarin (n, %) | 31 (31%) | 36 (36%) |
Statin (n, %) | 58 (57%) | 88 (92%) |
Patients could be on aspirin, warfarin or aspirin and warfarin therapy